HIV-@ prevention efficacy with emtricitabine plus tenofovir disoproxil fumarate was not significantly different from that of tenofovir disoproxil fumarate alone ( hazard ratio -LSB- HR -RSB- @ , @ % CI @-@ ; p = @ ) .